AI and probabilistic modelling applied to oncology

Improving the prediction of survival indicators in patients with breast cancer using tools from artificial intelligence and probabilistic modelling is the aim of ModGraProDep, an innovative system presented in a study led by Ramon Clèries, lecturer at the Department of Clinical Sciences of the Faculty of Medicine and Health Sciences and member of the Oncology Master Plan/ICO-IDIBELL.

Photo
The prediction of survival in patients -with specific variables and ages- is a decisive element to consider treatments and identify subgroups among the patients.
Source: University of Barcelona

One of the applications of numeric modelling for clinical indicators on oncology is the creation of predictive models to help oncologists and doctors to classify and value future scenarios of evolution in the patients with cancer. In this context, the prediction of survival in patients -with specific variables and ages- is a decisive element to consider treatments and identify subgroups among the patients. However, this information is sometimes estimated through numeric modelling since there is not enough sample population to calculate these indicators specifically.

The application of the new ModGraProDep Technology (Modelinng Graphical Probabilistic Dependencies) has led to two studies coordinated by the lecturer Mireia Vilardell, from the Section of Statistics at the Department of Genetics, Microbiology and Statistics of the Faculty of Biology of the UB, and the researcher Maria Buxó, from IDIBGI.

In the first case, ModGraProDep enables users to identify the structure of the database and to create a “synthetic” population of patients with the demographical features of the original cohort. With this new approach, they can identify potential patterns of patients and calculate indicators (for instance, the survival of a patient depending on the values of his or her variables). In a second study, ModGraProDep reveals itself as a new technology which can allocate values in a probabilistic manner in variables for which there was no information gathered yet.

The scientific team has designed a web application of great clinic interest in the field of oncology that enables having a prediction of indicators on survival and risk of cancer mortality -and other causes- of each patient for a maximum period of twenty years.

The new technology has been carried out by a team of experts on epidemiology, oncology and data management of the Oncology Master Plan – IDIBELL, the University of Barcelona, the Technical University of Catalonia, the Catalan Institute of Oncology (ICO), the Girona Biomedical Research Institute (IDIBGI), the University of Girona, the University of Alicante, the Epidemiology and Public Health Networking Biomedical Research Centre (CIBERESP), Carlos III Health Institute, the University Hospital Sant Joan de Reus, the Medical Oncology Service of ICO Girona, the Cancer Registry of Girona and Tarragona and the entity MC Mutual.

Subscribe to our newsletter

Related articles

AI challenge aims to improve mammography accuracy

AI challenge aims to improve mammography accuracy

AI techniques, used in combination with the evaluation of expert radiologists, improve the accuracy in detecting cancer using mammograms.

AI models could predict outcomes in trauma

AI models could predict outcomes in trauma

AI has shown early success in improving survival and outcomes in traffic accident victims transported by ambulance and in predicting survival after liver transplantation.

AI tool speeds up COVID-19 research

AI tool speeds up COVID-19 research

Computer scientists are aiming to speed up treatments and vaccines for COVID-19 — by making researchers’ jobs easier.

Google-powered AI spots breast cancer

Google-powered AI spots breast cancer

A computer algorithm has been shown to be as effective as human radiologists in spotting breast cancer from x-ray images.

AI predicts effectiveness of immunotherapy

AI predicts effectiveness of immunotherapy

Scientists can determine which lung-cancer patients will benefit from expensive immunotherapy.

Combination of AI and radiologists accurately identified breast cancer

Combination of AI and radiologists accurately identified breast cancer

An AI tool identified breast cancer with approximately 90 percent accuracy when combined with analysis by radiologists.

AI improves biomedical imaging

AI improves biomedical imaging

Researchers use artificial intelligence to improve quality of images recorded by a relatively new biomedical imaging method.

AI identified decision-relevant patterns in EEG of coma patients

AI identified decision-relevant patterns in EEG of coma patients

A research team has succeeded in identifying specific patterns in Electro-Encephalogram (EEG) analyses that the deep learning network uses for making prognosis decisions.

App uses AI to guide cancer patients

App uses AI to guide cancer patients

MyPath is a mobile application that gives breast cancer patients personalized recommendations on everything from side effects to insurance.

Popular articles